268 related articles for article (PubMed ID: 31612481)
1. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
2. Construction of hub transcription factor-microRNAs-messenger RNA regulatory network in recurrent implantation failure.
Luo J; Huang R; Xiao P; Xu A; Dong Z; Zhang L; Wu R; Qiu Y; Zhu L; Zhang R; Tang L
J Assist Reprod Genet; 2024 Jan; 41(1):3-13. PubMed ID: 37878219
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components.
Huang T; Ding J; Lin L; Han L; Yu L; Li M
Front Biosci (Landmark Ed); 2023 Nov; 28(11):293. PubMed ID: 38062833
[TBL] [Abstract][Full Text] [Related]
4. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
6. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
7. Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.
Liu Y; Li C; Dong L; Chen X; Fan R
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936304
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma.
Xu S; Liu D; Cui M; Zhang Y; Zhang Y; Guo S; Zhang H
Biomed Res Int; 2022; 2022():1893351. PubMed ID: 35774271
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.
Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P
Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999
[No Abstract] [Full Text] [Related]
10. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
[TBL] [Abstract][Full Text] [Related]
11. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics and validation reveal SOX12 as potential biomarker in colon adenocarcinoma based on an immune infiltration-related ceRNA network.
Chen X; Yang M; Tu J; Yuan X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15737-15762. PubMed ID: 37668799
[TBL] [Abstract][Full Text] [Related]
13. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
[TBL] [Abstract][Full Text] [Related]
14. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer.
Dong X; Zhang Y; Sun Y; Nan Q; Li M; Ma L; Zhang L; Luo J; Qi Y; Miao Y
BMC Med Genomics; 2023 Jun; 16(1):148. PubMed ID: 37370088
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Xiao D; Xie J; Wu S
Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Components in Colon Adenocarcinoma Using Transcriptome to Interactome Multilayer Framework.
Pournoor E; Mousavian Z; Dalini AN; Masoudi-Nejad A
Sci Rep; 2020 Mar; 10(1):4991. PubMed ID: 32193399
[TBL] [Abstract][Full Text] [Related]
19. ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma.
Yuan X; He Y; Wang W
Sci Rep; 2023 Oct; 13(1):16932. PubMed ID: 37805556
[TBL] [Abstract][Full Text] [Related]
20. Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.
Yu DH; Huang JY; Liu XP; Ruan XL; Chen C; Hu WD; Li S
Oncol Lett; 2020 Feb; 19(2):1203-1214. PubMed ID: 31966050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
